Figures & data
Table 1 Demographic and clinical characteristics of the study population
Figure 1 DMN and DAN of remitting-phase RRMS patients (right column) and HCs (left column) (one-sample t-test, p < 0.05, Bonferroni corrected). ICx: independent component x obtained by group ICA.
![Figure 1 DMN and DAN of remitting-phase RRMS patients (right column) and HCs (left column) (one-sample t-test, p < 0.05, Bonferroni corrected). ICx: independent component x obtained by group ICA.](/cms/asset/cf5b20d6-4cc0-47e7-964a-047c98ddc3b2/dndt_a_155478_f0001_c.jpg)
Figure 2 Compared with the HCs, significantly altered FC was observed in the remitting-phase RRMS patients (two-tailed voxel-level, p < 0.01; cluster-level, p < 0.05; GRF corrected).
![Figure 2 Compared with the HCs, significantly altered FC was observed in the remitting-phase RRMS patients (two-tailed voxel-level, p < 0.01; cluster-level, p < 0.05; GRF corrected).](/cms/asset/651d7fa2-30fb-4308-9d31-5cf285ce15a1/dndt_a_155478_f0002_c.jpg)
Table 2 Group comparisons of the ICs (subnetworks) of the DAN and DMN between the remitting-phase RRMS patients and the HCs
Figure 3 FNC analysis in the HCs and the remitting-phase RRMS patients.
![Figure 3 FNC analysis in the HCs and the remitting-phase RRMS patients.](/cms/asset/ac0b9bed-762b-45ef-b1cb-727e10bc6489/dndt_a_155478_f0003_c.jpg)
Figure 4 Significant alterations in the GCT in the spectral domain between the HCs and the remitting-phase RRMS patients.
Abbreviations: Corr, correlation; DAN, dorsal attention network; DMN, default mode network; GCT, Granger causality test; HC, healthy control; IC, independent component; MS, multiple sclerosis; RRMS, relapsing-remitting multiple sclerosis; val, value.
![Figure 4 Significant alterations in the GCT in the spectral domain between the HCs and the remitting-phase RRMS patients.](/cms/asset/17760a9a-fbe8-4f71-80d1-9e6aac312785/dndt_a_155478_f0004_c.jpg)
Figure 5 Correlations between the clinical measures (MFIS) and the altered connectivity coefficients of the remitting-phase RRMS patients.
![Figure 5 Correlations between the clinical measures (MFIS) and the altered connectivity coefficients of the remitting-phase RRMS patients.](/cms/asset/73f2fc01-8791-4352-b025-3c482724c6cf/dndt_a_155478_f0005_b.jpg)